ConductScience.org, home

Gene · 3489

Papers1,836

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

241 to 260 of 1,836

Download this page as JSON
TitleJournalYearPMIDFound bySource
Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease.BMC Genomics202336624378PubTator, text miningPubMed
Transcribed Ultraconserved Regions: New regulators in cancer signaling and potential biomarkers.Genet Mol Biol202336622962PubTator, text miningPubMed
Evolutionary analysis and functional characterization reveal the role of the insulin-like growth factor system in a diversified selection of chickens (Gallus gallus).Poult Sci202336587453PubTator, text miningPubMed
Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration.Nature202336544018PubTator, text miningPubMed
COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management.J Cell Mol Med202336537107PubTator, text miningPubMed
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study.Clin Chem202336508319PubTator, text miningPubMed
Proteomics analysis uncovers plasminogen activator PLAU as a target of the STING pathway for suppression of cancer cell migration and invasion.J Biol Chem202336496076PubTator, text miningPubMed
A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent Hepatocytes.Cancer Res202336449018PubTator, text miningPubMed
GPER1 links estrogens to centrosome amplification and chromosomal instability in human colon cells.Life Sci Alliance202336384894PubTator, text miningPubMed
Harnessing the synergy of perfusable muscle flap matrix and adipose-derived stem cells for prevascularization and macrophage polarization to reconstruct volumetric muscle loss.Bioact Mater202336382023PubTator, text miningPubMed
TCDD alters essential transcriptional regulators of osteogenic differentiation in multipotent mesenchymal stem cells.Toxicol Sci202336370075PubTator, text miningPubMed
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma.Cancer Immunol Immunother202335821528PubTator, text miningPubMed
Molecular cloning and expression profiling of insulin-like growth factor 2 and IGF-binding protein 6 in Clarias magur (Hamilton 1822).Anim Biotechnol202335714990PubTator, text miningPubMed
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma.Cancer Immunol Immunother202335654889PubTator, text miningPubMed
Diagnosis of triple negative breast cancer using expression data with several machine learning tools.Bioinformation202236909691PubTator, text miningPubMed
Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer.Front Oncol202236818671PubTator, text miningPubMed
Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome.Front Immunol202236741388PubTator, text miningPubMed
Single cell RNA sequencing research in maternal fetal interface.Front Cell Dev Biol202236704195PubTator, text miningPubMed
Systematic review of transcriptome and microRNAome associations with gestational diabetes mellitus.Front Endocrinol (Lausanne)202236704034PubTator, text miningPubMed
Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification.Ann Transl Med202236660701PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3489/papers?page=13